FDA Approved: LAZCLUZE — Supplemental Application (Janssen Biotech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LazCLUZE (lazertinib) from Janssen Biotech, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• LAZCLUZE (LAZERTINIB)

Snippet

SUPPL AP for LAZCLUZE (LAZERTINIB)